Blood Purification Equipment Market Outlook (2022-2033)

Rising Prevalence of Chronic Kidney Disease and Critical Illnesses

The market for blood purification systems has grown rapidly due to the enormous increase in the number of patients with chronic kidney disease, end stage renal disease, sepsis and acute kidney injury. Worldwide, diabetes and high blood pressure (hypertension) represent the two most important factors increasing the number of people with kidney failure and therefore requiring dialysis and blood purification treatments. Patients with advanced kidney disease must rely on lifelong or long-term treatments to remove toxins from their bodies and maintain metabolic balance. Blood purification technology is being used more often in intensive care units to help treat critically ill patients with inflammation by regulating their inflammatory mediators, treat patients with organ systems that have been damaged by infection or multiple organ failure and lower their risk of developing sepsis. The growth of the elderly population is driving this trend because older people are at higher risk of developing renal failure and other serious medical conditions that require external blood purification devices. Likewise, the ability of doctors and medical facilities to diagnose kidney diseases earlier and provide more people with access to services for treating these conditions have increased the number of patients being treated and are having an impact on the equipment utilized to treat patients. Hospitals and dialysis clinics continue to invest in the latest blood purification technologies to achieve better patient outcomes, increase operational efficiency and support increased patient demand. In conclusion, the rising number of patients with chronic kidney disease and increased reliance on medical devices for maintaining the viability of their kidneys will be the two major contributing factors to sustained market growth.

Expansion of Home-Based and Advanced Blood Purification Technologies

The blood purification equipment market is quickly expanding into this area of innovation (home-based therapies and advanced purification technologies). Healthcare systems want to relieve the burden on the hospital system by lowering treatment costs and improving Patient Quality of Life. As a result, healthcare systems are interested in home hemodialysis and Portable Dialysis Systems because of their ability to provide patients with the greatest amount of flexibility, convenience, and independence. This is particularly important for patients requiring long-term dialysis. New technological innovations, such as compact machines, automated systems, novel membrane materials, and smart monitoring capabilities, are increasing the safety and accessibility of blood purification at home.

Additionally, new advanced therapies such as hemoperfusion, immunoadsorption, and cytokine adsorption, along with a growing body of clinical research and clinical adoption in Critical Care, are gaining acceptance as important components of the treatment of conditions such as sepsis, auto imune disorders, and inflammatory syndromes. Because of the rapid growth of these advanced therapies in clinical practice, emerging markets throughout Asia Pacific, Latin America, and the Middle East, will provide substantial opportunities for Manufacturers who continue to offer patients advanced, cost-efficient technology that provides both improved clinical outcomes and increased long-term Market Share.

The "Blood Purification Equipment Market Size and Forecast (2022–2033)" report provides a detailed analysis of the market covering below areas:

• Blood Purification Equipment market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
• Blood Purification Equipment market trends, as well as market dynamics such as drivers, restraints, and key opportunities
• Blood Purification Equipment market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
• Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the Blood Purification Equipment market
• Detailed company profiles, including SWOT analysis

The geographical scope of the Blood Purification Equipment market report is divided into five regions: North America, Asia Pacific, Europe, Middle East and Africa, and South and Central America. The Blood Purification Equipment market in Asia Pacific is expected to grow significantly during the forecast period.

The Asia-Pacific Blood Purification Equipment market is segmented into China, Japan, South Korea, India, Australia, New Zealand, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Taiwan, Bangladesh, and the Rest of Asia. The number of patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD) is increasing in Asia-Pacific because of diabetes, high blood pressure, an aging society, and many other factors. Countries like China, India, Japan, and South Korea have some of the biggest CKD/ESRD populations and many more dialysis facilities are being developed and invested in. Governments in Asia-Pacific have also been taking steps to enhance their renal healthcare services; they have opened new dialysis centers and improved their reimbursement policy for renal services. The market has experienced significant growth due to the introduction of compact hemodialysis machines, newer technologies like continuous renal replacement therapy (CRRT) systems, and advanced hemoperfusion devices. Additionally, the continuing rise of intensive care units is likely to support further applications of blood purification processes for AKI and sepsis. While there is continued growth in the use of home-based dialysis because of a need to alleviate pressure on hospitals and provide convenience to patients, the Asia-Pacific blood purification equipment market remains a promising opportunity for investors due to the growing number of individuals with unmet clinical needs.  

• The report includes qualitative and quantitative data in the Blood Purification Equipment market across equipment type, modality, application, end user, and geography.
• The report starts with the key takeaways (chapter 2), highlighting the key trends and outlook of the Blood Purification Equipment market.
• Chapter 3 includes the research methodology of the study.
• Chapter 4 further includes ecosystem analysis.
• Chapter 5 highlights the major industry dynamics in the Blood Purification Equipment market, including factors that are driving the market, prevailing deterrents, potential opportunities, as well as future trends. Impact analysis of these drivers and restraints is also covered in this section.
• Chapter 6 discusses the Blood Purification Equipment market scenario, in terms of historical market revenues, and forecast till the year 2031.
• Chapters 7 to 10 cover Blood Purification Equipment market segments by equipment type, modality, application, end user, and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America. They cover the market volume revenue forecast and factors driving the market.
• Chapter 11 describes the competitive analysis along with the heat map analysis for the key players operating in the market.
• Chapter 12 describes the industry landscape analysis. It provides detailed descriptions of business activities such as market initiatives, new developments, mergers, and joint ventures globally, along with a competitive landscape.
• Chapter 13 provides detailed profiles of the major companies operating in the Blood Purification Equipment market. Companies have been profiled on the basis of their key facts, business descriptions, products and services, financial overview, SWOT analysis, and key developments.
• Chapter 14, i.e., the appendix is inclusive of a brief overview of the company, list of abbreviations, and disclaimer.

The Blood Purification Equipment market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the key developments in the blood purification equipment market are:

• In October 2024, CytoSorbents Corporation announced the US Food and Drug Administration (FDA) has accepted its De Novo medical device application for DrugSorb-ATR and initiated substantive review. The goal of DrugSorb-ATR, an investigational medical device, is to reduce the severity of perioperative bleeding in patients on ticagrelor (Brilinta, AstraZeneca) undergoing coronary artery bypass graft (CABG) surgery.
• In June 2024, CytoSorbents Corp has launched its PuriFi hemoperfusion machine in the European Union (EU), following approval and certification under the EU Medical Device Regulation (MDR).